MedImmune: The rationale for quadrivalent influenza vaccines 11 September 2012 / By Caroline Hornby / Flu, Prophylactic Vaccines, Regulation and Policy / 0 comments
Exploring the potential of a microbial detection array 9 September 2012 / By Freya Smale / Featured on App, R&D, Regulation and Policy / 0 comments
Developing a Scientifically Guided, Risk-Based Virus Safety Concept for a Cell-Derived Vaccine 8 September 2012 / By Freya Smale / Regulation and Policy / 0 comments
Viral contamination and continuous quality and safety of cell line produced vaccines 7 September 2012 / By Freya Smale / Featured on App, Regulation and Policy / 0 comments
From paternalism to country ownership of national immunization programs 26 August 2012 / By Freya Smale / Partnering and Corporate strategy, Regulation and Policy / 0 comments
The future of the 317 immunization program 24 August 2012 / By Freya Smale / Regulation and Policy / 0 comments
International collaboration to assess the risk of Guillain Barre Syndrome 20 August 2012 / By Freya Smale / Partnering and Corporate strategy, Regulation and Policy / 0 comments
6 influenza vaccines approved by the FDA 16 August 2012 / By Caroline Hornby / Flu, Regulation and Policy / 0 comments
What it takes to run a successful national immunization programme 15 August 2012 / By justine / Featured on App, Regulation and Policy / 0 comments
Download: Improving the response time to contain influenza pandemics 13 August 2012 / By winnie / Events, Featured on App, R&D, Regulation and Policy / 0 comments
